Last week’s story on Zyn being the “Ozempic for the masses” got picked up by Business Insider , NY Post, and Daily Mail, ha! The commentary is just as you’d expect.
What we’re discussing in this issue—
Like we predicted—2024 is the year of Ozempic dupes
Favorite food shows are not on food networks
Curating carbs and omakase bread
Frozen cottage cheese is t…